Publications by authors named "Tanner H"

Context: Guidelines for use of injectable estradiol esters (valerate [EV] and cypionate [EC]) among transgender and gender diverse (TGD) individuals designated male at birth vary considerably, with many providers noting supraphysiologic serum estradiol concentrations based on current dosing recommendations.

Objectives: 1. Determine dose of injectable estradiol (subcutaneous [SC] and intramuscular [IM]) needed to reach guideline-recommended estradiol concentrations for TGD adults using EC/EV.

View Article and Find Full Text PDF

Background: Early recurrences of atrial tachyarrhythmias (ERATs) after pulmonary vein isolation (PVI) are common. While many correlate to late recurrences (LRs), some do not. The impact of ERATs timing is difficult to assess with noninvasive Holter monitoring because of undersampling.

View Article and Find Full Text PDF

Background: Anticoagulant therapy prevents thrombosis and thromboembolic events in patients with mechanical heart valves. Bridging anticoagulation around the time of birth represents a unique challenge. Few retrospective reviews or case series exist examining peripartum outcomes with bridging anticoagulation.

View Article and Find Full Text PDF
Article Synopsis
  • Single-shot devices, like the Arctic Front cryoballoon, are becoming popular for pulmonary vein isolation in atrial fibrillation, with a new option, the FARAPULSE pulsed field ablation device, aiming for better safety and effectiveness.
  • The SINGLE SHOT CHAMPION trial involves 210 patients with paroxysmal atrial fibrillation randomly assigned to either the FARAPULSE or the cryoballoon treatment, with thorough monitoring for outcomes.
  • The study's primary focus is on the first recurrence of atrial tachyarrhythmias within a year after the procedure, alongside safety measures and quality of life assessments.
View Article and Find Full Text PDF
Article Synopsis
  • - The study compared the effects of dexmedetomidine and propofol on heart function in patients undergoing atrial fibrillation ablation, focusing on how each sedative impacts sinus node function and atrioventricular (AV) conduction.
  • - A total of 160 patients were enrolled, with findings indicating that patients given dexmedetomidine experienced slower sinus rates and prolonged AV conduction times compared to those given propofol.
  • - Despite these differences, both sedatives did not significantly affect certain aspects of heart conduction, such as infrahissian AV conduction and ventricular repolarization, and arrhythmia occurrence was similar across both groups.
View Article and Find Full Text PDF

Background: The Society of Australia and New Zealand (SOMANZ) published its first sepsis in pregnancy and the postpartum period guideline in 2017 (Aust N Z J Obstet Gynaecol, 57, 2017, 540). In the intervening 6 years, maternal mortality from sepsis has remained static.

Aims: To update clinical practice with a review of the subsequent literature.

View Article and Find Full Text PDF

Background: Pulsed-field ablation (PFA) is a novel nonthermal ablation technology. Its potential value for repeat procedures after unsuccessful thermal ablation for atrial fibrillation has not been assessed.

Objective: The purpose of this study was to summarize our initial experience with patients undergoing repeat procedures using PFA.

View Article and Find Full Text PDF

Introduction: Hypertensive disorders of pregnancy (HDP) affect up to 10% of all pregnancies annually and are associated with an increased risk of maternal and fetal morbidity and mortality. This guideline represents an update of the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) guidelines for the management of hypertensive disorders of pregnancy 2014 and has been approved by the National Health and Medical Research Council (NHMRC) under section 14A of the National Health and Medical Research Council Act 1992. In approving the guideline recommendations, NHMRC considers that the guideline meets NHMRC's standard for clinical practice guidelines.

View Article and Find Full Text PDF
Article Synopsis
  • Pulmonary vein isolation is an effective treatment for atrial fibrillation, with cryoballoon ablation being superior to medication; the study compares the new PolarX cryoballoon with the existing Arctic Front cryoballoon.
  • Patients with symptomatic paroxysmal atrial fibrillation were randomly assigned to receive either cryoballoon treatment and monitored for recurrence of atrial tachyarrhythmias and procedural safety within one year.
  • Results showed that the PolarX cryoballoon had a similar effectiveness compared to Arctic Front but caused significantly more cases of phrenic nerve palsies (5% vs. 0%).
View Article and Find Full Text PDF

Aims: Pacemaker (PM) patients may require a subsequent upgrade to an implantable cardioverter defibrillator (ICD). Limited data exists on this patient population. We sought to characterize this population, to assess predictors for ICD upgrade, and to report the outcome.

View Article and Find Full Text PDF

Background: Recurrence of paroxysmal atrial fibrillation (AF) following pulmonary vein isolation (PVI) is presumably caused by pulmonary vein (PV) reconnections. However, there is little data available on the durability of PVI and incidence of arrhythmia recurrence in patients with persistent AF.

Objectives: The purpose of this study was to evaluate the lesion durability by means of an a priori planned remapping procedure in patients with persistent AF undergoing CLOSE-guided PVI.

View Article and Find Full Text PDF

Background: Pulsed-field ablation (PFA) has shown promising data in terms of safety and procedural efficiency for pulmonary vein isolation (PVI), with similar long-term outcomes compared to radiofrequency ablation (RFA) and cryoballoon ablation (CBA) in patients with paroxysmal atrial fibrillation (AF).

Objective: The purpose of this study was to compare the procedural and long-term outcomes in patients with persistent AF undergoing PVI using PFA, CBA, or RFA.

Methods: Consecutive patients with persistent AF undergoing first PVI with PFA, CBA, or RFA were included.

View Article and Find Full Text PDF

Aims: Pulmonary vein isolation (PVI) is increasingly performed in patients with atrial fibrillation (AF). Both AF phenotype and left atrial (LA) volume have been shown to influence ablation outcome. The inter-relationship of the two is incompletely understood.

View Article and Find Full Text PDF

Heterogeneous multi-agent systems can be deployed to complete a variety of tasks, including some that are impossible using a single generic modality. This paper introduces an approach to solving the problem of cooperative behavior planning in small heterogeneous robot teams where members can both function independently as well as physically interact with each other in ways that give rise to additional functionality. This approach enables, for the first time, the cooperative completion of tasks that are infeasible when using any single modality from those agents comprising the team.

View Article and Find Full Text PDF

Background: Screening for atrial fibrillation (AF) may reveal incidental arrhythmias of relevance. The aim of this study was to describe incidental arrhythmias detected during screening for AF in the STAR-FIB (Predicting SilenT AtRial FIBrillation in Patients at High Thrombembolic Risk) cohort study.

Methods And Results: In the STAR-FIB cohort study, we screened hospitalized patients for AF with 3 repeat 7-day Holter ECGs.

View Article and Find Full Text PDF

Cardiac arrhythmias are a leading cause of mortality worldwide. Wearable devices based on photoplethysmography give the opportunity to screen large populations, hence allowing for an earlier detection of pathological rhythms that might reduce the risks of complications and medical costs. While most of beat detection algorithms have been evaluated on normal sinus rhythm or atrial fibrillation recordings, the performance of these algorithms in patients with other cardiac arrhythmias, such as ventricular tachycardia or bigeminy, remain unknown to date.

View Article and Find Full Text PDF

Aims: The left atrial posterior wall is a potential ablation target in patients with recurrent atrial fibrillation despite durable pulmonary vein isolation or in patients with roof-dependent atrial tachycardia (AT). Pulsed-field ablation (PFA) offers efficient and safe posterior wall ablation (PWA), but available data are scarce.

Methods And Results: Consecutive patients undergoing PWA using PFA were included.

View Article and Find Full Text PDF

Objectives: Epicardial adipose tissue (EAT) remodeling is associated with atrial fibrillation (AF). Left atrial (LA) EAT dispersion on cardiac CT is a non-invasive imaging biomarker reflecting EAT heterogeneity. We aimed to investigate the association of LA EAT dispersion with AF recurrence after pulmonary vein isolation (PVI).

View Article and Find Full Text PDF

Aims/hypothesis: Pregnant women are advised to consume a minimum of 175 g per day of carbohydrate to meet maternal and fetal brain glucose requirements. This recommendation comes from a theoretical calculation of carbohydrate requirements in pregnancy, rather than from clinical data. This study aimed to determine whether fasting maternal ketone levels are associated with habitual carbohydrate intake in a subset of participants of the Study of PRobiotics IN Gestational diabetes (SPRING) randomised controlled trial.

View Article and Find Full Text PDF

This paper presents a theoretical framework for probably approximately correct (PAC) multi-agent reinforcement learning (MARL) algorithms for Markov games. Using the idea of delayed Q-learning, the paper extends the well-known Nash Q-learning algorithm to build a new PAC MARL algorithm for general-sum Markov games. In addition to guiding the design of a provably PACMARL algorithm, the framework enables checking whether an arbitrary MARL algorithm is PAC.

View Article and Find Full Text PDF

Background: The provision of contraceptive care for incarcerated individuals has been largely inconsistent and has contributed to, at best, inadequate care, and at worst reproductive abuses, violence, and coercion. While previous research has identified strategies to remedy known issues, to date, very few recommendations have been implemented across the carceral system. To address this, we conducted a systematic review of policy and practice recommendations to improve contraceptive care to reproductive-aged, incarcerated individuals in the United States.

View Article and Find Full Text PDF

Aims: Implantation of an implantable cardiac monitor (ICM) is a simple procedure, but adds significant and increasing workload to the arrhythmia service. In 2020, we established a nurse-led ICM implantation service. We aimed to analyse patient satisfaction, adverse events during implant, and ICM re-interventions with nurse-led ICM implantation (N-Implant) compared to physician-led ICM implantation (P-Implant).

View Article and Find Full Text PDF

Background: Pulsed-field ablation (PFA) has shown favourable data in terms of safety and procedural efficiency for pulmonary vein isolation (PVI). We sought to compare procedural and 1-year follow-up data of patients with paroxysmal atrial fibrillation (AF) undergoing PVI using PFA, cryoballoon ablation (CBA) and radiofrequency ablation (RFA).

Methods: Consecutive patients with paroxysmal AF undergoing a first PVI with PFA at our institution were included.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the effectiveness of two cryoballoon devices (PolarX and Arctic Front) for treating atrial fibrillation through a multicenter, randomized clinical trial involving 200 patients.
  • The primary goal is to determine the time until the first recurrence of atrial tachyarrhythmias within a year after the procedure, alongside assessing procedural safety and various secondary outcomes like quality of life and repeat procedures.
  • The trial aims to provide insights on whether the new PolarX device can surpass the established Arctic Front technology for pulmonary vein isolation in patients experiencing their first episode of atrial fibrillation.
View Article and Find Full Text PDF